DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins

Claim 2

A DNA sequence selected from the group consisting of GAACAACAACAATGAAAAAAAGAAATAATGCGTGATTTTTTTGAAAKGGGAAG AAAAGGCCTTTTTTTATTACCAGTTATATGGCCCTCTTTTC; AAATAATCCTGAATCAAAATCGCAAGATAATGCAAATAAAGGAAATTATCTT TCTTTAAATATTGGTTATCGTAGTTTTGCTGATAAACCTGACTTGCTGATGG TTTTATTACAGTCCCAAAAGTTGGTAAAGAACTTAGTAAATCGACAATTATG GCTGATCCTGTCCCATAAAAAACAGGTAAAAAAAGTCATCGAAAACGGG CAAAAAATAGCAAAAGACCTTGGTGAA; GAATTCAAAGATGAGTTTAAAAAATACTGAACCTAATTTTTTTGTCGGCATC TATGAAAAGGCAATTGATAAACGTTTTTCTTTGATAGATAAAATTAAAATCG; GAATTCGACCGTAAGTGAAACACGTGATTTTATTCAAAAATTTGACATTTTC TATCAGGAAAATGTGGGCAAAATCAAAGAAGATTTAGATTTTGCAATAGCTC CAAGTTTTATATCTTTATCACTAATTICTAAGTCCTTGACTAAAAAATTAGA AATTGCTGCTCAAAATCTTAGTCAGTTTGATTCAGGAGCCTTTACTGGGGAA ATCAGTGGCAAAATGCTGCAGGATTTAGGGACAAAATATGTAATT; and GAATTCTGGACCTGTATATGGGCCATTTTTACCGGGCGAAGATAAGCGCGAA CTCAACCCAATTGTGGCAAAAAGTGCTAATTCAATCACAATTGATCTTAATA TTTTATCGATAATAACCAAAACAAAATTATCAGAGAGAGTTGCAGCCTTAAG CAGAGTTGAATTC.

Claim 3

A recombinant DNA molecule comprising a DNA sequence selected from the group consisting of (a) the DNA sequences GAACAACAATGAAAAAAAGAATAATGCGTGATTTTTTTGAAAGGGAAGAAAAGGCCTT TTTTATTACCAGTTATATGGCCCTCTTTTC; AAATAATCCTGAATCAAAATCGCAAGATAATGCAAATAAAGGAAATTATCTT TCTTTAAATATTGGTTATCGTAGTTTTGCT TTTTATTACAGTCCCAAAAGTTGGTAAAGAACTTAGTAAATCGACAATTATG TTGCTGATCCTGTCCCATAAAAAACAGGTAAAAAACAGTAAA AAAAGAGCTCATCGAAAACGGGCAAAAAATAGCAAAAGACCTTGTGAA; GAATTCAAAGATGAGTTTAAAAAATACTGAACCTAATTTTTTTGTCGGCATCTATGAAAAGG CAATTGATAAACGTTTTTCTTTGATAGATAAAATTAAAATCG; GAATTCGACCGTAAGTGAAAAIAGGTGATTTTATTCAAAAAATTTGACATTTTCTATCAGGAAA ATGTGGGCAAAAATCAAAGAAAAATTTAGATTTTGCAATAGCTCCAAGTTTTATATCTTTATCA CTAATTTCTAAGTCCTTGACTAAAAAATTAGAAATTGCTGCTCAAAATCTTAGTCAGTTTGA TTCAGGAGCCTTTACTGGGGAAATCAGTGGCAAAATGCTGCAGGATTTAGGGACAAAATATG TAATT; and GAATTCTGGACCTGTATATGGGCCATTTTTACCGGGCGAAGATAAGCGCGAACTCAACCCAA TTGTGGCAAAAAGTGCTAATTCAATCACAATTGATCTTAATATTTTATCGATAATAACCAAA ACAAAATTATCAGAGAGATTGCAGCCTTAAGCAG.AGTTGAATTC; and (b) DNA sequences that code on expression for a surface antigen of Mycoplasma hyopneumonia coded for on expression by any of the foregoing DNA sequences.

Claim 4

A recombinant DNA molecule comprising a DNA sequence selected from the group consisting of (a) the DNA sequences GAACAACAATGAAAAAAAGAATAATGCGTGATTTTTTTGAAAGGGAAGAAAAGGCCTT TTTTATTACCAGTTATATGGCCCTCTTTTC; AAATAATCCTGAATCAAAATCGCAAGATAATGCAAATAAAGGAAATTATCTT TCTTTAAATATTGGTTATCGTAGTTTTGCT TTTTATTACAGTCCCAAAAGTTGGTAAAGAACTTAGTAAATCGACAATTATG TTGCTGATCCTGTCCCATAAAAAACAGGTAAAAAACAGTAAA AAAAGAGCTCATCGAAAACGGGCAAAAAATAGCAAAAGACCTTGTGAA; GAATTCAAAGATGAGTTTAAAAAATACTGAACCTAATTTTTTTGTCGGCATCTATGAAAAGG CAATTGATAAACGTTTTTCTTTGATAGATAAAATTAAAATCG; GAATTCGACCGTAAGTGAAAAIAGGTGATTTTATTCAAAAAATTTGACATTTTCTATCAGGAAA ATGTGGGCAAAAATCAAAGAAAAATTTAGATTTTGCAATAGCTCCAAGTTTTATATCTTTATCA CTAATTTCTAAGTCCTTGACTAAAAAATTAGAAATTGCTGCTCAAAATCTTAGTCAGTTTGA TTCAGGAGCCTTTACTGGGGAAATCAGTGGCAAAATGCTGCAGGATTTAGGGACAAAATATG TAATT; and GAATTCTGGACCTGTATATGGGCCATTTTTACCGGGCGAAGATAAGCGCGAACTCAACCCAA TTGTGGCAAAAAGTGCTAATTCAATCACAATTGATCTTAATATTTTATCGATAATAACCAAA ACAAAATTATCAGAGAGATTGCAGCCTTAAGCAG.AGTTGAATTC; and (b) DNA sequences that code on expression for a surface antigen of Mycoplasma hyopneumonia coded for on expression by any of the foregoing DNA sequences.

Claim 5

A recombinant DNA molecule according to claim 2, wherein said DNA sequence is operatively linked to an expression control sequence in the recombinant DNA molecule.

Claim 6

A recombinant DNA molecule according to claim 3, wherein said expression control sequence is selected from the group consisting of the early and late promoters SV40[1 , the lac system, the TAC system, the TRC system, the trp system, major operator and promotor regions of phage λ the control regions of fd coat protein, the promoter for 3-phosphoglycerate kinase or other glycolytic enzymes, the promoters of acid phosphatase, the promoters of yeast α-mating factors, and other sequences which control the expression of genes of prokaryotic or eukaryotic cells or their viruses.

Claim 7

A recombinant DNA molecule according to claim 3 selected from the group consisting of pME1921, pME1922, pME1925, pME2413 and pME442.

Claim 8

A host transformed with the recombinant DNA molecule of any one of claims 2 to 5.

Claim 9

The transformed host according to claim 6, selected from the group consisting of strains of E.coli, Pseudomonas, Bacillus, yeasts, or other fungi, mouse, swine or other animal or plant hosts and human tissue cells.

Claim 10

The transformed host according to claim 7 wherein the E.coli is E.coli GCl.

Claim 11

The transformed host according to claim 8, wherein said host is selected from the group consisting of E.coli GCl (pcI857) (pME1921), E.coli GCl (pcI857) (pME1922), E.coli GCl (pcI857) (pME1925), E.coli GCl (pcI857) (pME2413), and E.coli GCl (pcI857) (pME442).

Claim 13

The method according to claim 10, wherein the host comprises strains of E.coli, Pseudomonas, Bacillus, yeast or other fungi, mouse, swine, or other animal or plant hosts and human tissue cells.